Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001594674-14-000004
Filing Date
2014-09-18
Accepted
2014-09-18 16:08:53
Documents
1
Period of Report
2014-09-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3354
  Complete submission text file 0001594674-14-000004.txt   4637
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
McDade Ralph L (Reporting) CIK: 0001594674 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 141110194